PMID
Cmpds
Data
Article Title
Organization
15
New indolizine-chalcones as potent inhibitors of human farnesyltransferase: Design, synthesis and biological evaluation.

Alexandru Ioan Cuza University
22
Highly improved antiparasitic activity after introduction of an N-benzylimidazole moiety on protein farnesyltransferase inhibitors.

Cnrs Upr2301
21
Novel indolizine derivatives with unprecedented inhibitory activity on human farnesyltransferase.

Alexandru Ioan Cuza University
12
Design, synthesis, and evaluation of sugar amino acid based inhibitors of protein prenyl transferases PFT and PGGT-1.

Leiden University
29
Design, synthesis, and structure-activity relationships of tetrahydroquinoline-based farnesyltransferase inhibitors.

Bristol Myers Squibb
1
Synthesis of acyloxymethyl ester prodrugs of the transferable protein farnesyl transferase substrate farnesyl methylenediphosphonate.

University of Kentucky
26
Dual protein farnesyltransferase-geranylgeranyltransferase-I inhibitors as potential cancer chemotherapeutic agents.

Merck Research Laboratories
9
Modeling of binding modes and inhibition mechanism of some natural ligands of farnesyl transferase using molecular docking.

University of Milan
8
Design, synthesis, and pharmacological evaluation of new farnesyl protein transferase inhibitors.

University of Lille
5
Successful virtual screening of a chemical database for farnesyltransferase inhibitor leads.

Mayo Medical School and Mayo Clinic
7
Novel farnesol and geranylgeraniol analogues: A potential new class of anticancer agents directed against protein prenylation.

Parke-Davis Pharmaceutical Research
15
Design and in vivo analysis of potent non-thiol inhibitors of farnesyl protein transferase.

Merck Research Laboratories
38
Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.

Merck Research Laboratories
30
Potent and selective non-cysteine-containing inhibitors of protein farnesyltransferase.

Abbott Laboratories
19
N-Arylalkyl pseudopeptide inhibitors of farnesyltransferase.

Merck Research Laboratories
8
Structural analysis of thrombin complexed with potent inhibitors incorporating a phenyl group as a peptide mimetic and aminopyridines as guanidine substitutes.

3-Dimensional Pharmaceuticals
47
Structure-activity relationships of cysteine-lacking pentapeptide derivatives that inhibit ras farnesyltransferase.

Warner-Lambert
42
Ras farnesyltransferase: a new therapeutic target.

Warner-Lambert
12
Design and synthesis of non-peptide Ras CAAX mimetics as potent farnesyltransferase inhibitors.

University of Pittsburgh
15
Pseudopeptide inhibitors of Ras farnesyl-protein transferase.

Merck Research Laboratories
22
Synthesis and evaluation of a novel series of farnesyl protein transferase inhibitors as non-peptidic CAAX tetrapeptide analogues.

Centre De Recherche Pierre Fabre
12
Cyclic acid anhydrides as a new class of potent, selective and non-peptidic inhibitors of geranylgeranyl transferase.

University College London
2
Aromatic farnesyl diphosphate analogues: vinyl triflate-mediated synthesis and preliminary enzymatic evaluation.

Wayne State University
45
2-Arylindole-3-acetamides: FPP-competitive inhibitors of farnesyl protein transferase.

Merck Research Laboratories
10
Grignard-mediated synthesis and preliminary biological evaluation of novel 3-substituted farnesyl diphosphate analogues.

Wayne State University
33
Synthesis and evaluation of hydroxyproline-derived isoprenyltransferase inhibitors.

Eisai Research Institute
28
Potent, non-thiol inhibitors of farnesyltransferase.

Merck Research Laboratories
6
Synthesis and evaluation of benzophenone-based photoaffinity labeling analogs of prenyl pyrophosphates containing stable amide linkages

TBA
7
Peptidomimetic inhibitors of p21ras farnesyltransferase: Hydrophobic functionalization leads to disruption of p21ras membrane association in whole cells

TBA
57
Structure-based design and synthesis of potent, ethylenediamine-based, mammalian farnesyltransferase inhibitors as anticancer agents.

Yale University
2
Sch 207278: a novel farnesyl protein transferase inhibitor from an unidentified fungus

TBA
5
Synthesis of triphosphonate analogues of farnesyl pyrophosphate. Inhibitors of squalene synthase and protein:farnesyl transferase

TBA
18
DIARYLETHER INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE

TBA
1
A cembranolide diterpene farnesyl protein transferase inhibitor from the marine soft coral
Lobophytum cristagalli
TBA
32
Novel tricyclic aminoacetyl and sulfonamide inhibitors of Ras farnesyl protein transferase

TBA
3
Oreganic acid: a potent novel inhibitor of ras farnesyl-protein transferase from an endophytic fungus

TBA
10
Inhibition of farnesyl protein transferase by new farnesyl phosphonate derivatives of phenylalanine

TBA
23
Phenolic replacements for cysteine in farnesyl transferase inhibitors based on CVFM

TBA
13
Local constrained shifty pseudopeptides inhibitors of rasfarnesyl transferase

TBA
12
Constrained analogs of KCVFM with improved inhibitory properties against farnesyl transferase

TBA
2
Stereochemistry of the benzodiazepine based Ras farnesyltransferase inhibitors

TBA
26
Peptide based P21
RAS farnesyl transferase inhibitors: systematic modification of the tetrapeptide CA
1A
2X motif

TBA
25
Cysteine and methionine linked by carbon pseudopeptides inhibit farnesyl transferase

TBA
13
Rational design of potent carboxylic acid based bisubstrate inhibitors of ras farnesyl protein transferase

TBA
41
Guiding farnesyltransferase inhibitors from an ECLiPS library to the catalytic zinc.

Pharmacopeia
68
Design and synthesis of o-trifluoromethylbiphenyl substituted 2-amino-nicotinonitriles as inhibitors of farnesyltransferase.

Abbott Laboratories
39
Synthesis and activity of 1-aryl-1'-imidazolyl methyl ethers as non-thiol farnesyltransferase inhibitors.

Abbott Laboratories
8
Design, synthesis, and activity of 4-quinolone and pyridone compounds as nonthiol-containing farnesyltransferase inhibitors.

Abbott Laboratories
16
Synthesis and biological evaluation of 1-benzyl-5-(3-biphenyl-2-yl-propyl)-1H-imidazole as novel farnesyltransferase inhibitor.

Abbott Laboratories
14
Synthesis of 1H-pyridin-2-one derivatives as potent and selective farnesyltransferase inhibitors.

Abbott Laboratories
1
Didehydrofarnesyl diphosphate: an intrinsically fluorescent inhibitor of protein farnesyltransferase.

The University of Utah
31
Synthesis of N,N'-disubstituted 3-aminobenzo[c] and [d]azepin-2-ones as potent and specific farnesyl transferase inhibitors.

Institut De Recherches Servier
21
Macrocyclic piperazinones as potent dual inhibitors of farnesyltransferase and geranylgeranyltransferase-I.

Merck Research Laboratories
6
Stable analogues of geranylgeranyl diphosphate possessing improved geranylgeranyl versus farnesyl protein transferase inhibitory selectivity.

Università
7
Substituted azoloquinolines and -quinazolines as new potent farnesyl protein transferase inhibitors.

Medicinal Chemistry Department Johnson & Johnson Pharmaceutical Research & Development (J&Jprd)
10
4-methyl-1,2,4-triazol-3-yl heterocycle as an alternative to the 1-methylimidazol-5-yl moiety in the farnesyltransferase inhibitor ZARNESTRA.

Medicinal Chemistry Department Johnson & Johnson Pharmaceutical Research & Development (J&Jprd)
44
Pyridone-containing farnesyltransferase inhibitors: synthesis and biological evaluation.

Abbott Laboratories
18
Synthesis and biological evaluation of 4-[(3-methyl-3H-imidazol-4-yl)-(2-phenylethynyl-benzyloxy)-methyl]-benzonitrile as novel farnesyltransferase inhibitor.

Abbott Laboratories
8
Pyrazino[1,2-a]indole-1,4-diones, simple analogues of gliotoxin, as selective inhibitors of geranylgeranyltransferase I.

Imperial College
6
Improvement of biological activity and proteolytic stability of peptides by coupling with a cyclic peptide.

Kyowa Hakko Kogyo
17
Discovery and structure-activity relationships of novel piperidine inhibitors of farnesyltransferase.

Pharmaceutical Research Institute
3
Antifungal activity of a Candida albicans GGTase I inhibitor-alanine conjugate. Inhibition of Rho1p prenylation in C. albicans.

Gpc Biotech
37
Discovery of potent imidazole and cyanophenyl containing farnesyltransferase inhibitors with improved oral bioavailability.

Abbott Laboratories
13
5-imidazolyl-quinolinones, -quinazolinones and -benzo-azepinones as farnesyltransferase inhibitors.

Johnson & Johnson Pharmaceutical Research & Development
7
A novel metal-chelating inhibitor of protein farnesyltransferase.

Kumamoto University
9
From pure FPP to mixed FPP and CAAX competitive inhibitors of farnesyl protein transferase.

Centre De Recherche Pierre Fabre
19
Novel and selective imidazole-containing biphenyl inhibitors of protein farnesyltransferase.

Abbott Laboratories
13
Aryl tetrahydropyridine inhibitors of farnesyltransferase: bioavailable analogues with improved cellular potency.

Abbott Laboratories
22
Synthesis and biological evaluation of 4-[3-biphenyl-2-yl-1-hydroxy-1-(3-methyl-3H-imidazol-4-yl)-prop-2-ynyl]-1-yl-benzonitrile as novel farnesyltransferase inhibitor.

Abbott Laboratories
20
The synthesis and biological evaluation of a series of potent dual inhibitors of farnesyl and geranyl-Geranyl protein transferases.

Merck Research Laboratories
19
Development of tripeptidyl farnesyltransferase inhibitors.

Department of Chemistry and School of Molecular Science(Bk21)
22
Potent inhibitors of farnesyltransferase and geranylgeranyltransferase-I.

Merck Research Laboratories
8
A new class of type I protein geranylgeranyltransferase (GGTase I) inhibitor.

Banyu Tsukuba Research Institute
44
Synthesis of 5,6-dihydro-11H-benzo[5,6]-cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidine-N-cyanoguanidine derivatives as inhibitors of ras farnesyl protein transferase.

Schering-Plough Research Institute
9
A novel class of highly potent, selective, and non-peptidic inhibitor of Ras farnesyltransferase (FTase).

Lgci
13
3-Aryl-4-aryloyl-1-(1H-imidazol-5-yl)methylpyrrole, a novel class of farnesyltransferase inhibitors.

Lgci
17
Exploration of novel aryl binding sites of farnesyltransferase using molecular modeling and benzophenone-based farnesyltransferase inhibitors.

Philipps-UniversitäT Marburg
32
Synthesis, molecular modeling, and structure-activity relationship of benzophenone-based CAAX-peptidomimetic farnesyltransferase inhibitors.

Philipps-UniversitäT Marburg
26
Evaluation of amino acid-based linkers in potent macrocyclic inhibitors of farnesyl-protein transferase.

Merck Research Laboratories
38
Diaryl ether inhibitors of farnesyl-protein transferase.

Merck Research Laboratories
15
Aryloxy substituted N-arylpiperazinones as dual inhibitors of farnesyltransferase and geranylgeranyltransferase-I.

Merck Research Laboratories
13
Peptidomimetic inhibitors of protein farnesyltransferase show potent antimalarial activity.

Yale University
14
Oxo-piperazine derivatives of N-arylpiperazinones as inhibitors of farnesyltransferase.

Merck Research Laboratories
4
Non-peptidic, non-prenylic inhibitors of the prenyl protein-specific protease Rce1.

Philipps-UniversitäT Marburg
7
3-Imidazolylmethylaminophenylsulfonyltetrahydroquinolines, a novel series of farnesyltransferase inhibitors.

Bristol Myers Squibb
22
Imidazole-containing diarylether and diarylsulfone inhibitors of farnesyl-protein transferase.

Merck Research Laboratories
27
Discovery of a series of cyclohexylethylamine-containing protein farnesyltransferase inhibitors exhibiting potent cellular activity.

Abbott Laboratories
27
Second-generation peptidomimetic inhibitors of protein farnesyltransferase demonstrating improved cellular potency and significant in vivo efficacy.

Abbott Laboratories
20
Non-thiol 3-aminomethylbenzamide inhibitors of farnesyl-protein transferase.

Merck Research Laboratories
7
Analogs of 4-(3-bromo-8-methyl-10-methoxy-6,11-dihydro-5H-benzo[5,6]-cyclo hepta[1,2-b]pyridin-11-yl)-1-(4-pyridinylacetyl)piperidine N-oxide as inhibitors of farnesyl protein transferase.

Schering-Plough Research Institute
27
Potent and orally bioavailable noncysteine-containing inhibitors of protein farnesyltransferase.

Abbott Laboratories
20
Potent, highly selective, and non-thiol inhibitors of protein geranylgeranyltransferase-I.

Yale University
34
Potent inhibitors of protein farnesyltransferase: heteroarenes as cysteine replacements.

Abbott Laboratories
9
Pharmaceutical significance of azepane based motifs for drug discovery: A critical review.

Wuhan Institute of Technology
7
Solid-phase synthesis of novel inhibitors of farnesyl transferase.

Institute of Cancer Research
25
Inhibitors of farnesyl protein transferase. Synthesis and biological activity of amide and cyanoguanidine derivatives containing a 5,11-dihydro[1]benzthiepin, benzoxepin, and benzazepin [4,3-b]pyridine ring system.

Schering-Plough Research Institute
4
Kampanols: novel Ras farnesyl-protein transferase inhibitors from Stachybotrys kampalensis.

Merck Research Laboratories
5
Design, synthesis, and biological evaluation of novel pyrrolo[1,2-a]pyrazine derivatives.

Yonsei University
11
A new class of highly potent farnesyl diphosphate-competitive inhibitors of farnesyltransferase.

Tsukuba Research Institute
18
C-terminal modifications of histidyl-N-benzylglycinamides to give improved inhibition of Ras farnesyltransferase, cellular activity, and anticancer activity in mice.

Warner-Lambert
9
Naphthalene, a versatile platform in medicinal chemistry: Sky-high perspective.

Indian Institute of Technology (Bhu)
11
Novel benzimidazole phosphonates as potential inhibitors of protein prenylation.

University of Iowa
7
2-substituted piperazines as constrained amino acids. Application to the synthesis of potent, non carboxylic acid inhibitors of farnesyltransferase.

Merck Research Laboratories
8
Phenothiazine-based CaaX competitive inhibitors of human farnesyltransferase bearing a cysteine, methionine, serine or valine moiety as a new family of antitumoral compounds.

Alexandru Ioan Cuza University
2
Farnesyltransferase inhibitors: CAAX mimetics based on different biaryl scaffolds.

University of Milan
18
Prenyltransferase Inhibitors: Treating Human Ailments from Cancer to Parasitic Infections.

University of Minnesota
26
New class of azaheptapyridine FPT inhibitors as potential cancer therapy agents.

Merck Research Laboratories
26
Synthesis and biological evaluation of a new series of N-ylides as protein farnesyltransferase inhibitors.

'Al. I. Cuza' University of Iasi
3
Neuroactive diol and acyloin metabolites from cone snail-associated bacteria.

University of Utah
4
Peptidomimetic modification improves cell permeation of bivalent farnesyltransferase inhibitors.

Osaka University
18
Synthesis and biological evaluation of a new series of phenothiazine-containing protein farnesyltransferase inhibitors.

Al. I. Cuza University of Iasi
26
Pseudodipeptide inhibitors of protein farnesyltransferase.

Merck Research Laboratories
4
Synthesis and biological evaluation of new phenothiazine derivatives bearing a pyrazole unit as protein farnesyltransferase inhibitors.

'Al. I. Cuza' University of Iasi
6
New farnesyltransferase inhibitors in the phenothiazine series.

Al. I. Cuza University of Iasi
13
Synthesis and anti-migrative evaluation of moverastin derivatives.

Keio University
20
Towards the synthesis of bisubstrate inhibitors of protein farnesyltransferase: Synthesis and biological evaluation of new farnesylpyrophosphate analogues.

Centre De Recherche De Gif-Sur-Yvette
30
Synthesis and structure-activity relationships of novel benzofuran farnesyltransferase inhibitors.

Chugai Pharmaceutical
1
Barceloneic acid A, a new farnesyl-protein transferase inhibitor from a Phoma species.

Merck Research Laboratories
9
Design, synthesis and biological evaluation of substituted dioxodibenzothiazepines and dibenzocycloheptanes as farnesyltransferase inhibitors.

University of Lille
19
Second generation tetrahydroquinoline-based protein farnesyltransferase inhibitors as antimalarials.

University of Washington
3
Synthesis, biochemical, and cellular evaluation of farnesyl monophosphate prodrugs as farnesyltransferase inhibitors.

Purdue University
42
3D-QSAR studies of farnesyltransferase inhibitors: a comparative molecular field analysis approach.

The M.S. University of Baroda
1
Methyllucidone inhibits STAT3 activity by regulating the expression of the protein tyrosine phosphatase MEG2 in DU145 prostate carcinoma cells.

Korea University of Science and Technology
21
Interrogating the Roles of Post-Translational Modifications of Non-Histone Proteins.

Temple University
119
Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme

Millennium Pharmaceuticals
6
Preparation method for benzoxazoleoxazine ketone compound and intermediate and crystal form thereof

North China Pharmaceutical New Drug R&D
88
Inhibitors of the renal outer medullary potassium channel

Merck Sharp & Dohme
147
Quinolone derivatives as fibroblast growth factor receptor inhibitors

Principia Biopharma
7
Triazolopyridyl compounds as aldosterone synthase inhibitors

Merck Sharp & Dohme
49
Amide derivatives and pharmaceutically acceptable salts thereof, preparation method thereof and medicinal application thereof

Jiangsu Hengrui Medicine
19
Macrocyclic compounds and their use as kinase inhibitors

Incyte
25
Rational design of 4,5-disubstituted-5,7-dihydro-pyrrolo[2,3-d]pyrimidin-6-ones as a novel class of inhibitors of epidermal growth factor receptor (EGF-R) and Her2(p185(erbB)) tyrosine kinases.

Sugen
50
Discovery of potent and selective SH2 inhibitors of the tyrosine kinase ZAP-70.

Ariad Pharmaceuticals